TY  - GEN
AU  - Talpaz,Moshe
AU  - Rakhit,Ashok
AU  - Rittweger,Karen
AU  - O'Brien,Susan
AU  - Cortes,Jorge
AU  - Fettner,Scott
AU  - Hooftman,Leon
AU  - Kantarjian,Hagop
TI  - Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemia
SN  - 1078-0432
PY  - 2005///1101
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Cytarabine
KW  - Drug Administration Schedule
KW  - Drug Carriers
KW  - Drug Combinations
KW  - Female
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Polyethylene Glycols
KW  - Recombinant Proteins
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
UR  - https://doi.org/10.1158/1078-0432.CCR-05-0882
ER  -